Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2020.340 | Response after End of Treatment with Antivirals in Chronic Hepatitis B |
Dr. HUI Aric Josun 許祖紳 |
| 2019.550 | CATALYST 207: A PHASE 2, PILOT, EXPLORATORY STUDY EVALUATING THE SAFETY AND ANTIVIRAL EFFICACY OF INARIGIVIR SOPROXIL IN NON-CIRRHOTIC TREATMENT-NAÏVE SUBJECTS INFECTED WITH CHRONIC HEPATITIS B VIRUS |
Dr. HUI Aric Josun 許祖紳醫生 |
| 2009.354 | A pharmacokinetic/pharmacodynamic evaluation of ABF656 in subjects with chronic hepatitis B, eAg+, infection | Dr Hui Aric Josun |
| 2010.464 | Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus Infection who are HBeAg-positive | Dr HUI Aric Josun |
| 2012.277 | A Phase 3, Randomized, Double-Blind, Controlled Study Evaluating the Efficacy and Safety of Peginterferon Lambda-1a, with and without Daclatasvir, Compared to Peginterferon Alfa-2a, Each in Combination with Ribavirin, in the Treatment of Na_ve Genotype 2 and 3 Chronic Hepatitis C Subjects | Dr Hui Aric Josun |
| 2012.350 | A multi-centre 3-year follow-up study to assess the viral activity in patients who failed to achieve sustained virologic response in Novartis-sponsored Alisporivir-studies for chronic Hepatitis C patients | Dr. HUI Aric Josun |
| 2011.225 | A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon α-2a (Pegasys®) versus Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Non-Cirrhotic Subjects with HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B (CHB) | Dr. Hui Aric Josun |
| 2011.180 | A randomized, double-blind, placebo-controlled trial of the efficacy and safety of DEB025/Alisporivir in combination with peg-IFN | Dr Hui Aric Josun |
| 2012.101 | A Structured Nurse-led Clinic after Open Access Endoscopy for Patients with Functional Dyspepsia: A Randomized Controlled Study | Dr. HUI Aric Josun |
| 2010.530 | A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of FG-3019 in Subjects with Liver Fibrosis due to Chronic Hepatitis B Infection | Dr. HUI Aric Josun |
| 2011.527 | Safety & Effectiveness of Nurse Performed Colonoscopies under Supervision: A Randomized Controlled Study in Asia (NE Study) | DR HUI ARIC JOSUN |
| 2013.117 | An Open Label, Phase 2a, Single-Arm Study of the Antifibrotic Activity of FG-3019 in Subjects with Advanced Liver Fibrosis due to Chronic Hepatitis C Infection (HCV) | Dr. Hui Aric Josun |
| 2012.550 | A multicenter open-label study to evaluate the safety and efficacy of PEG-Intron™ versus PEGASYS™ in subjects with HBeAg positive chronic hepatitis B and HBeAg negative chronic hepatitis B | Dr. HUI Aric Josun |
| 2012.352 | A multi-centre long-term follow-up study to assess the durability of sustained virologic response in alisporivir-treated chronic Hepatitis C patients | Dr. HUI Aric Josun |
| 2012.539 | An open-label trial of 48-week peginterferon alfa-2a (PGEASYS) to assess the sustained response of chroinc hepatitis B patients with HBeAg seroconversion on nucleot(s)ide analogue therapy | Dr. HUI Aric Josun |
| 2014.610 | A Risk Score derived from a large Gastrointestinal Bleeding Registry with Retrospective Validation | Dr. HUI Aric Josun |
| 2017.165 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) |
Dr. HUI Aric Josun 許祖紳 |
| 2015.290 | Direct Discharge of Patients with Upper gastrointestinal bleeding from the Emergency Department after Endoscopy: A Feasibility Study |
Dr. HUI Aric Josun 許祖紳 |
| 2017.164 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis |
Dr. HUI Aric Josun 許祖紳 |
| 2017.531 | A Phase 2, Open-label Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) in Virologically Suppressed Chronic Hepatitis B Subjects with Renal and/or Hepatic Impairment |
Dr. HUI Aric Josun 許祖紳醫生 |
| 2014.591 | A Phase IIB-III, open-label, randomized, comparative study to assess the efficacy of ABX203 to maintain control of Hepatitis B disease after cessation of treatment with nucleos(t)ide analogs in adult HBeAg negative patients with chronic Hepatitis B in the Asia Pacific region | Dr. HUI Aric Josun |
| 2014.590 | CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects with Liver Fibrosis | Dr. HUI Aric Josun |
| 2015.585 | The Hong Kong HCV Registry |
Dr. HUI Aric Josun 許祖紳 |
| 2009.247 | A Single-arm, Multinational, Two Year Study Evaluating the Efficacy and Safety of Lead-in Telbivudine for 24 Weeks with or without Tenofovir Treatment Intensification in Adult patients with HBeAg-positive Chronic Hepatitis B | Dr Hui Aric Josun |
| 2011.591 | Serum hepatitis B surface antigen levels to guide the stopping of entecavir in HbeAg-negative chronic hepatitis B | Dr Hui Aric Josun |
| 2012.421 | Double Balloon Enteroscopy in Hong Kong: Six years experience at a Single Center | DR HUI ARIC JOSUN |
| 2013.434 | Predictors of Colonoscopy Non-attendance and the Efficacy of a Short Message Service (SMS) Reminder to reduce Non-attendance Rate: A Prospective Randomized Controlled Trial (NAC Study) | Dr. HUI Aric Josun |
| 2013.250 | Clinical Outcomes of Patients with Obscure-Overt Gastrointestinal Bleeding: Analysis of a 13 year Gastrointestinal Bleed Registry | Dr. HUI Aric Josun |
| 2021.222 | Fertility and pregnancy outcomes for patients with cervical insufficiency managed with various treatments |
Dr HUI Annie Shuk Yi 許淑儀 |
| 2021.159 | Delayed-interval delivery in twin pregnancy |
Dr. HUI Annie Shuk Yi 許淑儀 |
| 2021.376 | Validation of TEG6s reference ranges in obstetric service |
Dr. HUI Annie Shuk Yi 許淑儀 |
| 2021.607 | Incidence of early and late onset group B streptococcal (GBS) & E. Coli infections in neonates- any change after implementation of universal screening of maternal GBS colonization with intrapartum antibiotics in all public hospitals in Hong Kong? | Dr. HUI Annie Shuk Yi |
| 2022.110 | The application of public funded exome & genome sequencing in prenatal diagnosis in Hong Kong | Dr. HUI Annie Shuk Yi |
| 2023.499 | Early-onset group B streptococcus disease in the era of universal culture-based screening- a multicentre retrospective study | Dr. HUI Annie Shuk Yi |
| 2017.442 | A study on the influence of maternal demographics, anthropometrics, and obstetric factors on obstetric and perinatal outcomes in the local population | Dr. HUI Annie S.Y. |
| 2015.317 | A multi-centered study on factors influencing the career interest in Obstetrics and Gynaecology of medical graduates in Hong Kong | Dr. HUI Annie |
| 2022.599 | Effects of a Nurse-led Common-sense Model of Self-regulation-based Heart Failure Self-care Program on Patient Outcomes: A Randomized Controlled Trial |
Mr. HUANG Zehao 黄泽浩 |
| 2016.340 | Targeted Delivery of microRNAs by Nanoparticles as a Novel Therapeutic Strategy in the Treatment of Atherosclerosis in Diabetes and Obesity |
Prof. HUANG Yu 黄聿 |
| 2015.243 | Identifying the epigenomic fingerprint of coronary heart disease in Chinese adults with type 2 diabetes. |
Dr. HUANG Yu 黃聿 |
| 2010.557 | A questionnaire-based study to investigate the eye care-seeking behaviors among Hong Kong Chinese adult with different oular symptoms | Ms Huang Yeung Chi |
| 2012.017 | Kinematic and electromyographic analysis in sprinting in mid-acceleration phase of male soccer players | Mr Huang Qi |
| 2023.350 | Prediction of pediatric obstructive sleep apnea based on visual photographic analysis. |
Mr. HUANG Minhao 黄旻浩 |
| 2018.228 | Establishing a Protocol for Cryopreservation of Human Adipose Tissue and Isolated Stromal Vascular Fraction | Dr. HUANG Lin |
| 2010.010 | The potential role of decoy receptor 3 in the pathogenesis of keloid scarring | Prof HUANG LIN |
| 2009.207 | A Study of the Functional Stem Cell Capacity of Human Umbilical Cord Lining Epithelia Cells | Prof Huang Lin |
| 2008.177 | Charactering the Expression and Function of MicroRNA in Keloid Disease | Prof Huang Lin |
| 2024.417 | Assessing Cancer Risk and Comorbidities in Diabetic vs. Non-Diabetic Patients in Hong Kong: a retrospective cohort study | Prof. HUANG Junjie |
| 2023.020 | Brain-first versus body-first Parkinson’s disease: case-control study with integrated multi-omics and imaging data | Dr. HUANG Bei |
| 2021.525 | Risk screening for prodromal Parkinson’s disease in elderly using smartphone | Dr. HUANG Bei |
| 2024.119 | Development of a novel gut microbiome-based diagnostic test for prodromal Parkinson's disease |
Dr. HUANG Bei 黄蓓 |
Page 153 of 254.